MedPath

DAPAGLIFLOZIN

These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral useInitial U.S. Approval: 2014

Approved
Approval ID

3aba33aa-f8c6-4b10-85c8-dfa14578d07c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 12, 2023

Manufacturers
FDA

PRASCO, LLC

DUNS: 065969375

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DAPAGLIFLOZIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66993-456
Application NumberNDA202293
Product Classification
M
Marketing Category
C73605
G
Generic Name
DAPAGLIFLOZIN
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 12, 2023
FDA Product Classification

INGREDIENTS (6)

DAPAGLIFLOZIN PROPANEDIOLActive
Quantity: 5 mg in 1 1
Code: 887K2391VH
Classification: ACTIM
CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
anhydrous lactoseInactive
Code: 3SY5LH9PMK
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

DAPAGLIFLOZIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66993-457
Application NumberNDA202293
Product Classification
M
Marketing Category
C73605
G
Generic Name
DAPAGLIFLOZIN
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 12, 2023
FDA Product Classification

INGREDIENTS (6)

CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561
Classification: IACT
DAPAGLIFLOZIN PROPANEDIOLActive
Quantity: 10 mg in 1 1
Code: 887K2391VH
Classification: ACTIM
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
anhydrous lactoseInactive
Code: 3SY5LH9PMK
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DAPAGLIFLOZIN - FDA Drug Approval Details